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With enormous speed novel data are emerging about
regulating the expression of the genetically encoded
information [1]. This highly complex regulatory network
called epigenetics includes acetylation, methylation,
phosphorylation, sumoylation and non-coding RNAs
(ncRNA), such as miRNA and lncRNAs. Our laboratory
is addressing over the past decade inflammatory rheu-
matic diseases [2], like rheumatoid arthritis (RA), AS,
SSc and pulmonary hypertension and thereby searching
for the regulation of pro-inflammatory cytokines [3,4],
novel diagnostic signatures and new therapeutic targets.
In this regard, DNA demethylation of RA synovial cells
can be modulated by targeting specific enzymes [5].
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